Author

Sarai Bardales

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 1

Frequent Co-Authors

Andyna VernetiD· 2 shared Aaron J. SchmitziD· 1 shared Adam M. Chazin-GrayiD· 1 shared Alex KangiD· 1 shared Ali H. EllebedyiD· 1 shared Amanda R. GravelineiD· 1 shared Andrew C. HuntiD· 1 shared Anjali RajwariD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Andyna VernetORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

De Novo Design of Miniprotein Inhibitors of Bacterial Adhesins

Adam M. Chazin-Gray, Tuscan Rock Thompson, Edward D. B. Lopatto, Pearl Magala, Patrick W. Erickson, Andrew C. Hunt, Anna A. Manchenko, Pavel Aprikian, Veronika L Tchesnokova, Irina Basova, Denise A. Sanick, Kevin O. Tamadonfar, Morgan R. Timm, Jerome S. Pinkner, Karen Dodson, , David A. Baker

This study designs miniprotein inhibitors targeting bacterial adhesins to prevent and treat urinary tract infections.

Nature Communications · Oct 9, 2026Peer-reviewedMicrobiology

Validation of DoriVac (DNA origami vaccine) efficacy in a metastatic melanoma model

Anjali Rajwar, Hawa Dembele, Amanda R. Graveline, Andyna Vernet, Melinda Sanchez, Sarai Bardales, Ick Chan Kwon, Ju Hee Ryu, William M. Shih, Yang C. Zeng

This study validates DoriVac, a DNA origami vaccine, as an effective treatment for metastatic melanoma in mouse models, showing reduced tumor nodules and enhanced immune activation when combined with PD-L1 blockade.

ACS Applied Materials & Interfaces · Apr 29, 2026Peer-reviewedSynthetic Biology